# PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)

> **NCT07089550** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 1300 (estimated)

## Conditions studied

- PSMA Positive Tumors or Tumor Tissues
- Prostate Cancer Metastatic

## Interventions

- **RADIATION:** PSMA PET/CT scan

## Key facts

- **NCT ID:** NCT07089550
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2034-04-26
- **Final completion:** 2034-04-26
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089550, "PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07089550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*